San Diego's Scripps Translational Science Institute will conduct the first study to assess whether people taking genetic tests will change their behavior, says this article in SciAm. Scripps will offer its 10,000 employees, family members, and friends of the nonprofit Scripps Health system Navigenics' genetic test, and changes in behavior will be assessed over a 20-year period. The study will be led by Eric Topol, director at Scripps.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.